Emergent BioSolutions Sees FY2026 Sales $720.000M-$760.000M vs $1.155B Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Emergent BioSolutions (NYSE:EBS) sees FY2026 sales of $720.000 million-$760.000 million vs $1.155 billion analyst estimate.
Emergent BioSolutions (NYSE:EBS) sees FY2026 sales of $720.000 million-$760.000 million vs $1.155 billion analyst estimate.